Colorectal Cancer Clinical Trial
Official title:
Patient Centered Outcomes Research Institute (PCORI) Provider Survey on Treatment Eligibility
Objectives:
1. Determine the surveillance practice patterns following curative resection of colorectal
cancer
2. Identify patient characteristics related to eligibility for treatment after the
detection of a colorectal cancer recurrence
A survey related to surveillance practice patterns following curative resection of
colorectal cancer patients will be administered to eligible providers for them to complete.
The survey collects basic information related to a providers' role in in colorectal care in
addition to their perspective on patient characteristics that may directly influence a
patients' ability to receive treatment for a recurrent colorectal cancer.
The surveys may be self-administered and completed anonymously, either in a hard copy or
electronic formats. They may also be administered by the research personnel in a group
setting for paper or electronic surveying. The surveys may be sent to providers as in PDF
form for respondents to print and complete, handed out in person, emailed as a qualtrics
study or electronically administered at a regularly occurring conference for colorectal
cancer physicians. In the case the survey is electronically administered in a group setting,
audience response equipment will be used. Individual data will be collected using electronic
response devices. No personally identifying information will be collected. Participants will
not be identifiable using data collected in these group settings. If the form is handed out
in person, it will be given out and collected using a blank envelope to eliminate any way of
identifying the provider completing it.
If respondents print and complete paper forms they will be ask to return them with no
identifying information. Participants will be asked to place the deidentified survey in a
sealed envelope and return through mail or in a drop-box placed in a common location, all
envelopes returned to the study staff in person will be collected together and opened in
aggregate. Electronically administered questionnaires, using audience response or a
qualtrics survey, will have no identifying information.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
| Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
| Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
| Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
| Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
| Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
| Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
| Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
| Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
| Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
| Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |